VitMode

Hair Loss, Acne, and Libido — Do They Share a Common Root Cause?

A receding hairline, stubborn acne, and swings in libido look like three separate problems — but in many men they're connected by one biological axis: testosterone, the enzyme 5-alpha-reductase, and the androgen receptor. We show how this axis genuinely links three seemingly unrelated symptoms, without repeating details we've already covered in our hair-loss articles.

AKdr Anna KowalczykSeptember 25, 202612 min read
Table of contents

Three problems, one question in the exam room

You're 29, 33, or 38. Your hairline at the temples is receding a bit faster than you'd like, acne you haven't had since high school keeps coming back along your jawline, and your libido is — there's no better word for it — uneven. Each of these three problems has its own explanation, its own article, its own specialist. But is it possible that in some men, all three stem from one shared source?

The answer is: yes, in some men there is a genuine shared biological axis — testosterone, the enzyme 5-alpha-reductase, dihydrotestosterone (DHT), and the androgen receptor — that can simultaneously affect hair follicles, sebaceous glands, and tissues tied to sexual function. That doesn't mean anyone with two of these three symptoms is dealing with exactly the same mechanism — but it's worth understanding what this connection actually looks like, instead of intuitively assuming "it's all testosterone."

This article doesn't replace our hair-loss pieces

The detailed mechanism of androgenetic alopecia and specific management strategies (finasteride, creatine and DHT) are covered in depth in separate articles — "Finasteride and Androgenetic Alopecia" and "Creatine, Hair Loss, and DHT." Here we're interested purely in what connects all three symptoms at once, not re-explaining each one individually.

The shared axis: testosterone → 5-alpha-reductase → DHT → androgen receptor

Testosterone circulating in the blood, on its own, has a limited effect on many target tissues. It's only after conversion by the enzyme 5-alpha-reductase into dihydrotestosterone (DHT) — a compound with several times higher affinity for the androgen receptor than testosterone itself — that strong activation of that receptor occurs in specific tissues. Crucially, this enzyme exists in two main isoforms (type 1 and type 2), distributed differently across tissues: type 1 dominates in the skin's sebaceous glands, while type 2 dominates in temporal/crown hair follicles and in reproductive-tract tissues.

This distribution explains why DHT can simultaneously miniaturize hair follicles at the temples (androgenetic alopecia), boost sebum production in the jaw and cheek sebaceous glands (acne), and — through the same androgen receptors also present in the central nervous system and genital tissues — affect sexual desire. Three different target organs, one shared molecular signal.

Indirect proof: what happens when the axis is artificially blocked

Strong evidence

The strongest evidence that this axis truly links all three tissues doesn't come from observing natural variation, but from what happens when it's pharmacologically blocked. Drugs that inhibit 5-alpha-reductase (finasteride, dutasteride), used precisely to lower DHT in the scalp and slow hair loss, also cause sexual side effects in some patients — reduced libido, erectile dysfunction, ejaculation problems. This shows that intervening in the DHT axis "in one place" (hair follicles) genuinely echoes in "another place" (sexual function) — proof that the axis is truly shared, not just theoretically connected.

Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review

Strong evidence

Fertig RM, Gamret AC, Darwin E, Gaudi S · Dermatology Online Journal · 2017

A systematic review found that 5-alpha-reductase inhibitors used to treat androgenetic alopecia are associated with an elevated risk of sexual dysfunction — reduced libido, erectile dysfunction, and ejaculation problems — in a subset of treated men. The authors note that blocking the conversion of testosterone to DHT affects not only peripheral tissues (skin, hair follicles) but also the central nervous system through changes in neurosteroid levels, which may explain effects on sexual desire independent of blood testosterone levels themselves.

View study

Why this does NOT mean high DHT lowers libido

Myth

If drugs that block DHT lower libido in some men, that means high DHT is good for libido, and more DHT is always better.

Fact

That's an overreach. Normal, physiological levels of DHT and androgen receptor activity support healthy libido — but there's no good evidence that raising DHT above normal further improves it. The relationship isn't linear: dropping clearly below normal (as with enzyme-blocking drugs) is harmful, but that doesn't mean more is always better — we cover this same "threshold, not a straight line" pattern in more depth in our article on testosterone and libido.

In other words: the testosterone-DHT-androgen receptor axis is shared across all three symptoms, but that doesn't mean they always move in the same direction. A man with strongly androgen-responsive skin and scalp (clear acne, early hairline recession) doesn't necessarily also have libido problems — for many such men libido is perfectly normal, because local follicle and sebaceous-gland sensitivity to DHT is a different variable from overall axis activity in the brain and genital tissues.

Genetics: why it all comes together in some men and not others

A key piece of the puzzle is genetically determined androgen receptor sensitivity, largely dependent on the length of so-called CAG repeats in the androgen receptor gene (shorter repeats generally mean higher tissue sensitivity to a given DHT level). This explains why two men with identical blood testosterone levels can have completely different clinical pictures — one with clear acne and early hair loss, the other with neither symptom — despite the same "amount of hormone" circulating in the body.

What actually determines whether the symptoms appear together

  • 5-alpha-reductase enzyme activity in a given tissue (skin, scalp) — genetically variable between individuals
  • Density and sensitivity of androgen receptors in a given tissue, partly dependent on CAG repeat length
  • Total testosterone pool available for conversion — influenced by diet, sleep, body weight, and stress
  • Independent, separate factors modifying each symptom on its own (e.g. stress worsening acne independent of DHT, fatigue lowering libido independent of hormones)

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

What this looks like in practice: three typical scenarios

ScenarioWhat's happeningWhat it suggests
Jawline acne + early hairline recession, normal libidoStrong local 5-AR activity in skin and scalp, normal systemic axis activityClassic picture of high tissue sensitivity to DHT without libido involvement — the most common pattern
All three symptoms at onceMay suggest broadly higher androgenic activity OR a coincidence of independent causes (stress, sleep, diet)Worth differentiating, not assuming one shared mechanism by default
Hair loss and acne improve on DHT-blocking drugs, but libido also dropsSide effect of a pharmacological intervention on the whole axis, not a natural courseEvidence that the axis is genuinely shared — but here it results from a deliberate intervention, not a spontaneous process

Three typical patterns of co-occurrence

What is NOT part of this shared axis

Not every case of co-occurrence has a shared cause

Acne can have a non-hormonal cause (cosmetics, diet, fungal folliculitis), hair loss can result from telogen effluvium after stress or from deficiencies (iron, zinc, biotin), and a drop in libido just as often has a psychological, sleep-related, or relationship source, entirely unrelated to DHT. Before concluding you're dealing with one shared androgenic mechanism, it's worth ruling out these independent, equally plausible explanations.

Don't self-prescribe DHT blockers "for everything at once"

Since finasteride and similar drugs affect the entire axis, using them on your own, without medical guidance, in hopes of improving skin and hair carries a genuine risk to libido and sexual function — sometimes reversible, sometimes, in a subset of men, persisting even after stopping the drug. This is a decision to make only with a doctor, never on your own.

What to do if you notice two or three of these symptoms

The first step isn't guessing — it's careful observation and, if symptoms are significant, a consultation. A dermatologist will assess acne and the hair-loss pattern clinically and, if in doubt, order hormone testing (total and free testosterone, SHBG, sometimes DHEA-S). If a libido problem is clear-cut and persistent rather than fleeting, it's worth a separate consultation — our broad article on ten causes of low libido in men gives wider diagnostic context beyond the DHT axis alone.

Specific strategies for managing androgenetic alopecia — from finasteride to supportive supplementation, including whether creatine actually raises DHT enough to matter clinically — are covered in the dedicated articles linked above. We deliberately don't repeat those details here, to avoid diluting this piece's core message: that these three symptoms may, or may not, share a common source.

Limits of this model

Three co-occurring symptoms are still just a clue, not a diagnosis

Even in men with all three symptoms at once, the DHT axis is rarely the only factor at play. Age, chronic stress, sleep quality, diet, body weight, and coexisting conditions (e.g. insulin resistance) modify each of these three symptoms independently, which makes it hard to conclusively say "it's definitely DHT" without a full workup.

Patients who notice two or three of these symptoms at once often assume one dramatic shared cause. In practice we most often find a mix: some genuinely shared biology, and some entirely independent causes that simply happened to coincide in time.

Dr. Anna Kowalczyk, dermatologist, VitMode editorial team

Frequently asked questions

No. Local sensitivity of sebaceous glands and hair follicles to DHT are two separate, though related, variables — you can have one symptom pronounced without the other, depending on the genetically determined distribution of androgen receptors.

Not necessarily, and often the opposite. A drop in libido is more often linked to low, not high, testosterone, or to causes entirely unrelated to hormones (stress, sleep, relationships). Acne and hair loss alone don't tell you your testosterone level without bloodwork.

Yes, that's a documented risk — finasteride acts systemically on the whole 5-alpha-reductase axis, not only locally in the scalp, which is why it causes sexual side effects in some men. This is a topic to discuss with a doctor before starting therapy, not after.

They're a segment of the androgen receptor gene whose length correlates with tissue sensitivity to DHT — shorter repeats usually mean higher sensitivity. This is one reason two men with identical testosterone levels can have very different degrees of acne or hair loss.

Yes, it's worth consulting a doctor and considering a basic panel (total and free testosterone, SHBG), especially if symptoms are pronounced or appeared relatively suddenly. The result will help distinguish a shared hormonal cause from a coincidence of independent causes.

This question is genuinely debated, and the answer isn't clear-cut — we cover the scientific evidence in detail in our article on creatine, hair loss, and DHT. In short: the evidence for a clinically meaningful DHT increase from creatine supplementation is limited and mixed.

We don't recommend that. The co-occurrence of these three symptoms is a clue, not a diagnosis — each of them also has causes unrelated to DHT, and a final assessment requires a clinical exam and, often, bloodwork.

Sources

AK

dr Anna Kowalczyk

PhD in Molecular Biology (University of Warsaw), 8 years researching cellular aging

Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.

Related articles

Related knowledge base entries

Zestaw probówek z niebieskimi zatyczkami w laboratoryjnym stojaku4.5

SHBG (Sex Hormone-Binding Globulin)

A transport protein whose level determines how much testosterone is actually 'available' to tissues — without knowing SHBG, a total testosterone result alone can be misleading.

TRTStrong evidence
Dłonie liczące wydatki na kalkulatorze wśród paragonów4.5

How Much Does TRT Cost? The Price of Testosterone Therapy in Poland [2026]

What does testosterone replacement therapy actually cost in Poland? We break the expense down into its components — diagnostics, consultations, medication (injections vs. gel), and monitoring — and explain why, for most men, TRT is in practice a private, out-of-pocket service rather than something covered by public health insurance.

TRTModerate evidence
Strzykawka i leki na jasnej powierzchni4.4

TRT — Administration Forms: Injections, Gels, and Patches

Injections, transdermal gels, and patches — the three main forms of testosterone replacement therapy differ in blood-concentration profile, ease of use, and the risk of transferring the hormone to other people.

TRTStrong evidence
Umięśniony sportowiec w stroju treningowym4.7

Testosterone

The primary anabolic hormone — its natural level depends heavily on sleep, resistance training, body composition and fat mass.

HormonyStrong evidence
Lekarz mierzący ciśnienie krwi pacjenta w gabinecie4.7

TRT — Side Effects and Therapy Monitoring

Erythrocytosis, fertility impact, PSA screening, and the cardiovascular risk question — what testosterone replacement therapy safety actually involves and how it's monitored.

TRTStrong evidence
Kobieta leżąca na kanapie i trzymająca się za brzuch4.7

Endometriosis

A chronic disease affecting about 10% of women of reproductive age, still diagnosed with a multi-year delay on average — despite pain severe enough to significantly disrupt daily functioning.

Zdrowie kobietStrong evidence

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.